News
News from us and our partners
News
Capital
News
News
Capital
News
Biovelocita
News
Crossover
News
Capital
News
Seven years: the journey behind Myricx's acquisition by Novartis
In memory of Denis Lucquin, Sofinnova chairman
Sofinnova Partners closes Capital XI at €650M
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
CEO spotlight: Thierry Abribat's third straight win
Johnson & Johnson to acquire Shockwave Medical
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
Sofinnova Partners appoints David Evans as Partner
- News
Seven years: the journey behind Myricx's acquisition by Novartis
- News
Abivax Announces Closing of $920 Million Public Offering
- News
Sofinnova Partners announces Myricx Bio agrees to be acquired by Novartis
- News
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
- News
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
- News
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
- News
Partnership with French cancer research network FFCD expands Bioptimus’s STELA programme
- News
Moon Surgical and Uncovr Announce First 20 Clinical Cases of Automated Operative Reporting on Maestro®
- News
Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database
- News
“Health is Wealth”: Why Europe must act now to strengthen its Life Sciences industry
- News
Mediar Therapeutics Announces First Cohorts Dosed in Phase 1 Clinical Trial of MTX-439 for Fibrosis Associated with Chronic Kidney Disease (CKD) and Additions to Clinical Advisory Board
- News
TISSIUM secures €60 million to support commercial and clinical activities and platform expansion
- News
BrightHeart Announces CE Mark and European Launch of its AI Platform for Prenatal Ultrasound
- News
Micropep Files First Regulatory Submissions for Promisin™, a Novel Peptide Biofungicide with a New Mode of Action